Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 13
Phase 22

Trial Status

Completed2
Terminated1

Role Distribution

Principal Investigator1
Other Roles2
PI Rate33%

Activity Timeline

Research Network

Collaboration Network

7 collaborators·6 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Vivek Roy, M.D.

Mayo Clinic

Related
3 trials

Shared therapeutic areas:

Refractory Multiple MyelomaMultiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Collaborated on 1 trial
Similarity Score24%

George Somlo, MD

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Refractory Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Jorge Cortes, MD

M.D. Anderson Cancer Center

Related
24 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Mohamad A. Hussein, MD

The Cleveland Clinic

Related
8 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

William I. Bensinger, MD

Fred Hutchinson Cancer Center

Related
12 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Thomas E. Witzig, MD

Mayo Clinic

Related
12 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Similarity Score15%

Charles L. Loprinzi, MD

Mayo Clinic

Related
14 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

Mayo ClinicNational Cancer Institute (NCI)
Similarity Score15%

Jeffrey S. Weber, MD, PhD

University of Southern California

Related
9 trials

Shared therapeutic areas:

Multiple Myeloma and Plasma Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Refractory Multiple Myeloma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT01049945Phase 1/2StudyChair

Bendamustine Hydrochloride, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

Refractory Multiple Myeloma
Completed
NCT00687674Phase 1StudyChair

Sorafenib, Lenalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm
Terminated
NCT01034553Phase 1/2PrincipalInvestigator

Aurora A Kinase Inhibitor MLN8237 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma

Refractory Multiple Myeloma
Completed

All 3 trials loaded